Ovarian Tissue Cryopreservation for Pediatric Cancer Patients

N/A

Waitlist Available

Led By Zaraq Khan, M.B.B.S.

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Female, age birth-17 years

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial is designed to offer ovarian tissue cryopreservation to female pediatric patients with fertility threatening medical diagnoses.

Who is the study for?

This trial is for girls from birth to 17 years old with conditions that threaten fertility, such as cancer or Turner's syndrome. They must be facing treatments like surgery, chemo, or radiation that could harm their ovaries. Girls who can't fully consent or have severe ovarian damage aren't eligible.

What is being tested?

The study offers ovarian tissue cryopreservation—an experimental procedure to save and freeze ovarian tissue—to young female patients at risk of losing reproductive potential due to medical treatments.

What are the potential side effects?

Since this is a preservation technique rather than a drug treatment, the main risks involve surgical complications and the effects of anesthesia required for the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a girl 17 years old or younger.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Ovarian tissue cryopreservationExperimental Treatment1 Intervention

Children faced with a fertility threatening diagnosis or treatment plan will be offered ovarian tissue cryopreservation, particularly if pre menarchal and without other options to preserve fertility. Although considered experimental, there are over 120 live births worldwide using this technique

0 / 1Eligibility criteria met